Single nucleotide polymorphisms in fibroblast growth factor 23 gene, FGF23, are associated with prostate cancer risk

BJU International

Volumn 114, Issue 2, 2014, Pages 303-310

  Kim, Hae Jong ^a,b   Kim, Kyeoung Hwa ^a,b   Lee, Jaehyouk ^a   Oh, Jong Jin ^c   Cheong, Hyun Sub ^d   Wong, Ee Lin ^e,f   Yang, Beom Seok ^e,f   Byun, Seok Soo ^g   Myung, Soon Chul ^a,b  

^a Chung Ang University College of Medicine   (South Korea)

^b Chung Ang University   (South Korea)

^c CHA University   (South Korea)

^d SNP Genetics Inc   (South Korea)

^e Korea Institute of Science and Technology   (South Korea)

^f University of Science and Technology (UST)   (South Korea)

^g Seoul National University Bundang Hospital   (South Korea)

Author keywords

FGF23; polymorphism; prostate cancer

Indexed keywords

FIBROBLAST GROWTH FACTOR 23;

AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FGF23 GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

FGF23; POLYMORPHISM; PROSTATE CANCER;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FIBROBLAST GROWTH FACTORS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; REPUBLIC OF KOREA;

EID: 84905089200     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12396     Document Type: Article

References (29)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300
2. Park SK, Sakoda LC, Kang D, et al. Rising prostate cancer rates in South Korea. Prostate 2006; 66: 1285-1291
3. Chan JM, Holick CN, Leitzmann MF, et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control 2006; 17: 199-208
4. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45-51
5. Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science 2005; 309: 1829-1833
6. Itoh N,. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res 2010; 342: 1-11
7. Yu X, Ibrahimi OA, Goetz R, et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 2005; 146: 4647-4656
8. Kurosu H, Ogawa Y, Miyoshi M, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 2006; 281: 6120-6123
9. Marsell R, Jonsson KB,. The phosphate regulating hormone fibroblast growth factor-23. Acta Physiol (Oxf) 2010; 200: 97-106
10. Haussler MR, Haussler CA, Whitfield GK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the 'Fountain of Youth' to mediate healthful aging. J Steroid Biochem Mol Biol 2010; 121: 88-97
11. Huynh H, Pollak M, Zhang JC,. Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089. Int J Oncol 1998; 13: 137-143
12. Boyle BJ, Zhao XY, Cohen P, Feldman D,. Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. J Urol 2001; 165: 1319-1324
13. Tovar Sepulveda VA, Falzon M,. Regulation of PTH-related protein gene expression by vitamin D in PC-3 prostate cancer cells. Mol Cell Endocrinol 2002; 190: 115-124
14. Blutt SE, McDonnell TJ, Polek TC, Weigel NL,. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 2000; 141: 10-17
15. Blutt SE, Allegretto EA, Pike JW, Weigel NL,. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 1997; 138: 1491-1497
16. Zhuang SH, Burnstein KL,. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 1998; 139: 1197-1207
17. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW,. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer Causes Control 1995; 6: 235-239
18. Tebben PJ, Kalli KR, Cliby WA, et al. Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clin Proc 2005; 80: 745-751
19. Jacobs E, Martinez ME, Buckmeier J, Lance P, May M, Jurutka P,. Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma. J Carcinog 2011; 10: 3
20. Song SY, Kim SR, Ahn G, Choi HY,. Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients. Prostate Cancer Prostatic Dis 2003; 6: 143-147
21. Livak KJ,. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 1999; 14: 143-149
22. Morris JA, Gardner MJ,. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J (Clin Res Ed) 1988; 296: 1313-1316
23. Hedrick PW,. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117: 331-341
24. Stephens M, Smith NJ, Donnelly P,. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989
25. Nyholt DR,. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769
26. Rendina D, Esposito T, Mossetti G, et al. A functional allelic variant of the FGF23 gene is associated with renal phosphate leak in calcium nephrolithiasis. J Clin Endocrinol Metab 2012; 97: E840-844
27. Elstner E, Linker-Israeli M, Umiel T, et al. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res 1996; 56: 3570-3576
28. Liu S, Quarles LD,. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007; 18: 1637-1647
29. Kim DK, Kim SJ, Moon HS, et al. The role of TURP in the detection of prostate cancer in BPH patients with previously negative prostate biopsy. Korean J Urol 2010; 51: 313-317